Literature DB >> 14502263

Reduced levels of T-cell subsets CD4+ and CD8+ in homozygous sickle cell anaemia patients with splenic defects.

K Gustave Koffi1, Duni Sawadogo, Mori Meite, Danho Clotaire Nanho, Estelle S Tanoh, Alain Koffi Attia, Ibrahim Sanogo, Amadou Sangare.   

Abstract

T-lymphocyte subsets were studied in two patient groups: (1) 50 patients with homozygous sickle cell anaemia (SCA) (mean age 12 (range 3-32) years old) in good health at the time of the study who showed no infectious complication. (2) 50 patients (mean age 13 (range 4-29) years old) with normal haemoglobin rate. The global response revealed a significant increase in levels of CD3+ (P=0.04) and CD8+ (P=0.04) cells when compared with the control group, there was no significant difference in levels of CD4+ cells (P=0.05) between the two groups. However, there was a relationship between T-cell subpopulation levels and spleen status. The average values of T-cell subsets (CD4+ and CD8+) in patients with SCA-induced splenic defects (asplenic, splenomegaly or splenectomized patients) were significantly reduced when compared to SCA patients with normal spleens and the control groups. These data show that T-cell activity was reduced in patients with splenic defects. A correlation between splenic status and a perturbed host defence system in patients with SCA suggests that monitoring T-cell subsets might have prognostic value in the course of sickle cell disease.

Entities:  

Mesh:

Year:  2003        PMID: 14502263     DOI: 10.1038/sj.thj.6200310

Source DB:  PubMed          Journal:  Hematol J        ISSN: 1466-4860


  14 in total

1.  Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major.

Authors:  Weili Bao; Hui Zhong; Xiaojuan Li; Margaret T Lee; Joseph Schwartz; Sujit Sheth; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2011-09-26       Impact factor: 10.047

2.  COVID-19 and Vulnerable Populations in Sub-Saharan Africa.

Authors:  J A George; M R Maphayi; T Pillay
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Immunological role of CD4+CD28null T lymphocytes, natural killer cells, and interferon-gamma in pediatric patients with sickle cell disease: relation to disease severity and response to therapy.

Authors:  Mohsen Saleh ElAlfy; Amira Abdel Moneam Adly; Fatma Soliman ElSayed Ebeid; Deena Samir Eissa; Eman Abdel Rahman Ismail; Yasser Hassan Mohammed; Manar Elsayed Ahmed; Aya Sayed Saad
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

Review 4.  Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.

Authors:  Emmanuel Balandya; Teri Reynolds; Stephen Obaro; Julie Makani
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

5.  Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial.

Authors:  Arielle L Langer; Andrew Leader; Seunghee Kim-Schulze; Yelena Ginzburg; Miriam Merad; Jeffrey Glassberg
Journal:  Ann Hematol       Date:  2019-02-20       Impact factor: 3.673

6.  Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.

Authors:  Bolanle O P Musa; Geoffrey C Onyemelukwe; Joseph O Hambolu; Aisha I Mamman; Albarka H Isa
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

Review 7.  Sickle cell anemia patient with sarcoidosis-associated inguinal lymph node and lung infiltration.

Authors:  Birol Güvenç; Cagatay Unsal; Ismail Hanta; Aydan Unsal; Hakan Güvenç
Journal:  J Natl Med Assoc       Date:  2005-06       Impact factor: 1.798

8.  CD4+ T Lymphocytes count in sickle cell anaemia patients attending a tertiary hospital.

Authors:  Omotola Toyin Ojo; Wuraola Adebola Shokunbi
Journal:  Niger Med J       Date:  2014-05

9.  Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis.

Authors:  Nadja Pinto Garcia; Alexander Leonardo S Júnior; Geyse Adriana S Soares; Thainá Cristina C Costa; Alicia Patrine C Dos Santos; Allyson Guimarães Costa; Andréa Monteiro Tarragô; Rejane Nina Martins; Flávia do Carmo Leão Pontes; Emerson Garcia de Almeida; Erich Vinícius de Paula; Olindo Assis Martins-Filho; Adriana Malheiro
Journal:  J Immunol Res       Date:  2020-01-08       Impact factor: 4.818

Review 10.  Life-Threatening Infectious Complications in Sickle Cell Disease: A Concise Narrative Review.

Authors:  Dominik Ochocinski; Mansi Dalal; L Vandy Black; Silvana Carr; Judy Lew; Kevin Sullivan; Niranjan Kissoon
Journal:  Front Pediatr       Date:  2020-02-20       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.